Evergreen Capital Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
16,353
+10,162
+164% +$670K 0.02% 493
2026
Q1
$427K Buy
6,191
+1,080
+21% +$84.4K 0.01% 891
2025
Q4
$450K Sell
5,111
-896
-15% -$76.3K 0.01% 802
2025
Q3
$500K Buy
6,007
+1,694
+39% +$148K 0.01% 660
2025
Q2
$403K Sell
4,313
-303
-7% -$28.7K 0.01% 654
2025
Q1
$488K Buy
4,616
+108
+2% +$11.1K 0.02% 518
2024
Q4
$436K Buy
4,508
+150
+3% +$14.9K 0.01% 562
2024
Q3
$431K Buy
4,358
+393
+10% +$36K 0.01% 565
2024
Q2
$341K Buy
3,965
+469
+13% +$36.9K 0.01% 610
2024
Q1
$265K Buy
3,496
+142
+4% +$11K 0.01% 682
2023
Q4
$255K Sell
3,354
-251
-7% -$17.5K 0.01% 667
2023
Q3
$249K Sell
3,605
-35
-1% -$2.52K 0.01% 627
2023
Q2
$304K Buy
3,640
+358
+11% +$29.1K 0.01% 545
2023
Q1
$243K Buy
3,282
+266
+9% +$18.7K 0.01% 590
2022
Q4
$213K Buy
+3,016
New +$201K 0.01% 592

Other funds holding MMSI

Evergreen Capital Management's MMSI Position: Q2 2026 in Review

Evergreen Capital Management increased its Merit Medical Systems (MMSI) stake by 164% in Q2 2026, buying an estimated $670K and bringing the position to 16,353 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #493.

Evergreen Capital Management first reported a position in MMSI in Q4 2022 and has held it in 15 quarters since. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Evergreen Capital Management held 16,353 shares of Merit Medical Systems worth $1.13M as of Q2 2026.
  • Evergreen Capital Management bought 10,162 Merit Medical Systems shares in Q2 2026, an estimated $670K.
  • Merit Medical Systems made up 0.02% of Evergreen Capital Management's portfolio in Q2 2026, its #493 holding.
  • Evergreen Capital Management first reported a position in Merit Medical Systems in Q4 2022 and has held it in 15 quarters since.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.